Drug giant Merck pays $300M to acquire Seattle biotech company Immune Design by James Thorne on February 21, 2019February 21, 2019 at 2:35 pm Merck, one of the world’s largest drugmakers, agreed to buy Seattle-based biotechnology company Immune Design for $300 million in cash. The deal’s price tag, at $5.85 per share, amounted to… Read More